Feyza Gul Ozbay Kurt

• Graduate School Scholarship Programme (GSSP), German Academic Exchange Service (DAAD), 10/2020, 10/2023
• International Molecular Immunology and Immunogenetics Congress (MIMIC IV) Travel Grant, Bursa, Turkey, 04/27/2019, 04/29/2019
• European Cooperation in Science and Technology (COST) Travel Grant, COST Action [BM1404] event: 6th MC/WG Meeting and ECI Workshop/Conference; 1st European Conference on Myeloid Regulatory Cells, Essen, Germany, 11/01/2018, 11/03/2018
• The European Federation of Immunological Societies (EFIS) Travel Grant, 5th European Congress of Immunology (ECI 2018), Amsterdam, Netherlands, 09/02/2018, 09/05/2018

• Feyza Gul Ozbay Kurt, Beatrice Ana Cicortas, Rebekka Bitsch, Jochen Utikal, Viktor Umansky, S100A9 and HMGB1 regulates the immunosuppression by MDSC in melanoma, 24-27 April 2023, Oral Presentation
• Feyza Gul Ozbay Kurt, Rebekka Weber, Jochen Utikal, Viktor Umansky, The role of TLR4 signaling in myeloid cell mediated immune suppression in melanoma, Hallmarks of Skin Cancer Conference, 29 November 2021, Poster Presentation
• Feyza Gul Ozbay Kurt, Rebekka Weber, Jochen Utikal, Viktor Umansky, The role of TLR4 signaling in myeloid cell mediated immune suppression in melanoma, 18TH CIMT Annual Meeting, 10-12 May 2021, eTalk
• Feyza Gul Ozbay, Gunes Esendagli, Evaluation of T cell responses in the co-cultures established with neutrophils, monocytes, and lung adenocarcinoma cells, Onkolojide Iz Birakanlar Zirvesi, Antalya, Turkey, 14-16 November 2019, Oral Presentation
• Pinar Acar-Ozen, Asli Tuncer, Didem Ozkazanc, Feyza Gul Ozbay, Beren Karaosmanoglu, Sibel Goksen, Ekim Taskiran, Gunes Esendagli, Rana Karabudak, Transcriptomic and immunophenotypic analyses on natural killer cells in RRMS patients under fingolimod therapy, 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Stockholm, Sweden, 11-13 September 2019, Poster Presentation
• Stephan Winklmeier, Miriam Schluter, Melania Spadaro, Franziska S. Thaler, Atay Vural1,, Ramona Gerhards, Caterina Macrini, Asli Kurne3, Berin Inan, Gunes Esendagli, Feyza Gul Ozbay, Reinhard Hohlfeld, Tania Kumpfel, Edgar Meinl, Circulating myelin oligodendrocyte glycoprotein (MOG)-specific B cells stratify patients with MOG-antibodies, II Joint Meeting of the German Society for Immunology (DGfl) and the Italian Society of Immunology, Munich, Germany, 10-13 September 2019, Poster Presentation
• Feyza Gul Ozbay, Gunes Esendagli, Neutrophils reinforce cytotoxic T cell responses in a co-culture model mimicking tumor microenvironment in lung cancer, International Molecular Immunology and Immunogenetics Congress (MIMIC IV), Bursa, Turkey, 27-29 April 2019, Poster Presentation
• Feyza Gul Ozbay, Gunes Esendagli, Evaluation of cytotoxic T cell responses in a co-culture model employing neutrophils, monocytes, and lung cancer cells, 1st European Symposium on Myeloid Regulatory Cells in Health and Disease (ESMRC), Essen, Germany, 1-3 November 2018, Poster Presentation
• Feyza Gul Ozbay, Gunes Esendagli, Evaluation of helper T cell proliferation in the co-cultures of lung adenocarcinoma cells, neutrophils, and monocytes, European Congress of Immunology (ECI 2018), Amsterdam, Netherlands, 2-5 September 2018, Poster Presentation

• Lasser S.; Özbay Kurt, F.G.; Arkhypov I.; Utikal J.; Umansky V., Myeloid-derived suppressor cells in cancer and cancer therapy, Nat Rev Clin Oncol, 2024, 21, 2, 147-164, 10.1038/s41571-023-00846-y
• Lepper A.; Bitsch R.; Özbay Kurt, F.G.; Arkhypov I.; Lasser S.; Utikal J.; Umansky V., Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs, Oncoimmunology, 2023, 12, 1, 2247303
• Zbay Kurt, F.G.; Lasser S.; Arkhypov I.; Utikal J.; Umansky V., Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target, J Clin Invest, 2023, 133, 13, e170762
• Zbay Kurt, F.G.; Lepper, A.; Gerhards, C.; Roemer, M.; Lasser, S.; Arkhypov, I.; Bitsch, R.; Bugert, P.; Altevogt, P.; Gouttefangeas,C.; Neumaier M.; Utikal J.; Umansky V., Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2, Front Immunol, 2022, 13, 1012526
• Arkhypov, I.,Ozbay Kurt, F.G, Bitsch, R.; Novak, D.; Petrova, V.; Lasser, S.; Hielscher, T.; Groth, C.; Lepper, A.; Hu, X; Li, Wi; Utikal, J; Altevogt P; Umansky, V., HSP90alpha induces immunosuppressive myeloid cells in melanoma via TLR4 signaling, J Immunother Cancer, 2022, 10, e005551
• Bitsch R, Kurzay A, Ozbay Kurt F, De La Torre C, Lasser S, Lepper A, Siebenmorgen A, Muller V, Altevogt P, Utikal J, Umansky V., STAT3 inhibitor napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice, J Immunother Cancer, 2022
• Christopher Groth, Rebekka Weber, Samantha Lasser, Feyza Gül Özbay, Annina Kurzay, Vera Petrova, Peter Altevogt, Jochen Utikal, Viktor Umansky, Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization, International Journal of Cancer, 2021, July, 10.1002/ijc.33731
• M. Alper Kursunel, Ekim Z. Taskiran, Ece Tavukcuoglu, Hamdullah Yanik, Funda Demirag, Beren Karaosmanoglu, Feyza Gul Ozbay, Aysegul Uner, Dorina Esendagli, Derya Kizilgoz, Ulku Yilmaz, Gunes Esendagli, Cancer Immunology, Immunotherapy, 2021, July, 10.1007/s00262-021-02998-1
• Nazire Pinar Acar, Asli Tuncer, Didem Ozkazanc, Feyza Gul Ozbay, Beren Karaosmanoglu, Sibel Goksen, Ekim Taskiran, Gunes Esendagli, Rana Karabudak, An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-β1 and fingolimod therapy, Journal of Neuroimmunology, 2020, July, 347, 577353, 10.1016/j.jneuroim.2020.577353
• Sayiner O., Arisoy S., Comoglu T., Ozbay F.G., Esendagli G., Development and in vitro evaluation for temozolomide-loaded PLGA nanoparticles in a thermoreversible hydrogel system for local administration in glioblastoma multiforme, Journal of Drug Delivery Science and Technology, 2020, February, 57, 101627, 10.1016/j.jddst.2020.101627
• Winklmeier S., Schluter M.,Spadora M, Thaler F.S, Vural A., Gerhards R., Macrini C., Mader S., Kurne A., Inan B., Karabudak R., Ozbay F.G., Esendagli G., Hohfeld R., Kumpfel T., Meinl E., Identification of circulating MOG-specific B cells in patients with MOG-antibodies, Neurol Neuroimmunol Neuroinflamm, 2019, October, 6, 5, e625

• The Project of Leonardo Da Vinci, Bucharest, Romania, May 2012, Providing career skills for students with disabilities
• Comenius Project, Manchester, England, May 2009, Focused on environmental pollution and recycling

• Quantifying systemic immunosuppression to personalize cancer therapy (SERPENTINE), Researcher, 2020, today
• Targeting MDSC-mediated immunosuppression in melanoma, Researcher, 2020-2024.
• Transcriptomic profiling of MDSC from melanoma patients in combination with an in vitro suppression of T cell proliferation assay, Researcher, 2020-2021
• Evaluation of T cell responses in the co-cultures of lung adenocarcinoma cells, neutrophils, and monocytes, Researcher, 2017-2020
• Hacettepe University Scientific Research Projects Coordination Unit Development and in vitro evaluation of temozolomide-loaded PLGA nanoparticles in a thermoreversible hydrogel system for local administration in glioblastoma multiforme, Researcher, 2019-2020
• Transcriptomic and immunophenotypic analyses on natural killer cells in multiple sclerosis patients under fingolimod therapy, Researcher, 2018-2019
• Circulating myelin oligodendrocyte glycoprotein (MOG)-specific B cells stratify patients with MOG-antibodies, Researcher, 2018-2019

Merianstr. 1, 69117, Heidelberg, Germany